Yo Han Bae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yo Han Bae has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Woo Sung Jang
Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Hospital, Keimyung University College of Medicine, Daegu, Korea
7 shared publications - Kyungsub Song
Department of Thoracic and Cardiovascular Surgery, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea
5 shared publications - Yun Seok Kim
Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
5 shared publications - Hee Jeong Lee
Division of Cardiology, Department of Internal Medicine, Cardiovascular Center, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
3 shared publications - Jonghoon Yoo
Department of Emergency Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea
3 shared publications - Jung Uk Woo
Medical Course, School of Medicine, Keimyung University College of Medicine, Daegu, Korea
3 shared publications
Latest Publications
- Open Access
Clinical and Molecular Associations of ITGB1 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: A TCGA-Based Study
Background/Objectives: Integrin beta 1 (ITGB1) participates in cell–extracellular matrix signaling, but its associations with clinical outcomes and molecular features in non-small cell lung cancer (NSCLC) may vary by histological subtype. We reassessed its clinical and transcriptomic associations in TCGA lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), explicitly testing interaction effects and microenvironmental confounding. Methods: Primary-tumor RNA-sequencing profiles from 492 LUAD and 488 LUSC patients were linked to standardized TCGA Clinical Data Resource outcomes. We performed median-based Kaplan–Meier analysis; Cox models of continuous ITGB1 expression per within-subtype standard deviation, with stage-stratified clinical adjustment; a common nine-gene expression correlation panel; ESTIMATE-score sensitivity analyses; tumor DNA mutation/copy-number comparisons; and phenotype-permutation Hallmark gene set enrichment analysis (GSEA). Results: After clinical and stromal/immune score adjustment, elevated ITGB1 expression was significantly associated with poor overall survival in LUAD (hazard ratio [HR] = 1.357, 95% confidence interval [CI]: 1.145–1.610) and favorable overall survival in LUSC (HR = 0.741, 95% CI: 0.627–0.876). Higher ITGB1 expression was also associated with PFI in LUAD (HR 1.240) and LUSC (HR 1.333), but survival interaction by histology was not significant (OS p = 0.198; PFI p = 0.724). ITGB1 correlations with KRAS and PIK3CA were stronger in LUAD than LUSC even after microenvironmental adjustment. SOX2 and PIK3CA amplification showed significant histology interactions with ITGB1 expression (adjusted interaction β = −0.651 and −0.613). Gene set enrichment analysis (GSEA) revealed within-cohort enrichment patterns associated with ITGB1 expression, highlighting pathways such as EMT, angiogenesis, and coagulation in LUAD, whereas MYC Targets, E2F Targets, and DNA Repair were enriched in LUSC. These findings represent within-cohort enrichment patterns and do not establish statistically significant differences between histologies. Conclusions: ITGB1 exhibits histology-associated molecular and microenvironmental patterns, without convincing evidence of differing survival hazard ratios between LUAD and LUSC. These retrospective findings require independent and functional validation.
Open AccessClinical and Molecular Associations of ITGB1 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: A TCGA-Based Study
Background/Objectives: Integrin beta 1 (ITGB1) participates in cell–extracellular matrix signaling, but its associations with clinical outcomes and molecular features in non-small cell lung cancer (NSCLC) may vary by histological subtype. We reassessed its clinical and transcriptomic associations in TCGA lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), explicitly testing interaction effects and microenvironmental confounding. Methods: Primary-tumor RNA-sequencing profiles from 492 LUAD and 488 LUSC patients were linked to standardized TCGA Clinical Data Resource outcomes. We performed median-based Kaplan–Meier analysis; Cox models of continuous ITGB1 expression per within-subtype standard deviation, with stage-stratified clinical adjustment; a common nine-gene expression correlation panel; ESTIMATE-score sensitivity analyses; tumor DNA mutation/copy-number comparisons; and phenotype-permutation Hallmark gene set enrichment analysis (GSEA). Results: After clinical and stromal/immune score adjustment, elevated ITGB1 expression was significantly associated with poor overall survival in LUAD (hazard ratio [HR] = 1.357, 95% confidence interval [CI]: 1.145–1.610) and favorable overall survival in LUSC (HR = 0.741, 95% CI: 0.627–0.876). Higher ITGB1 expression was also associated with PFI in LUAD (HR 1.240) and LUSC (HR 1.333), but survival interaction by histology was not significant (OS p = 0.198; PFI p = 0.724). ITGB1 correlations with KRAS and PIK3CA were stronger in LUAD than LUSC even after microenvironmental adjustment. SOX2 and PIK3CA amplification showed significant histology interactions with ITGB1 expression (adjusted interaction β = −0.651 and −0.613). Gene set enrichment analysis (GSEA) revealed within-cohort enrichment patterns associated with ITGB1 expression, highlighting pathways such as EMT, angiogenesis, and coagulation in LUAD, whereas MYC Targets, E2F Targets, and DNA Repair were enriched in LUSC. These findings represent within-cohort enrichment patterns and do not establish statistically significant differences between histologies. Conclusions: ITGB1 exhibits histology-associated molecular and microenvironmental patterns, without convincing evidence of differing survival hazard ratios between LUAD and LUSC. These retrospective findings require independent and functional validation.
- Open Access
- 1 May 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (5) , 475
Pacemaker implantation after concomitant maze procedure and mitral valve repair in atrial functional mitral regurgitation
Background: Atrial functional mitral regurgitation (AFMR) is caused by atrial enlargement and mitral annular dilation due to atrial fibrillation (AF). Although the outcomes of mitral valve surgery in AFMR have been reported, concomitant Maze procedure outcomes in AFMR remain poorly understood. This study aimed to evaluate the clinical and rhythm outcomes of concomitant mitral valve plasty and the Maze procedure in patients with AFMR. Methods: We retrospectively analyzed 122 patients who underwent the mitral valve plasty (repair) concomitant with Maze procedure between August 2010 and June 2025. The cohort was divided into an AFMR group (n=50) and a non-AFMR group (n=72). The cumulative incidence of permanent pacemaker (PPM) implantation was analyzed using the Fine-Gray subdistribution hazard model with death as a competing risk. Postoperative rhythm dynamics were evaluated using a continuous-time multi-state Markov model. Results: The overall cumulative incidence of PPM implantation was significantly higher in the AFMR group than in the non-AFMR group (P30 days) PPM implantation (PConclusions: AFMR was not associated with a statistically significant difference in overall survival and the incidence of major adverse cardiovascular events following the Maze procedure compared to the non-AFMR group. However, AFMR was associated with a higher risk of transition to junctional rhythm following the Maze procedure, which was associated with an increased rate of PPM implantation. Notably, the risk of pacemaker implantation was predominantly late-onset, which may be due to a progressive decline in sinus node function. Therefore, close long-term rhythm monitoring and follow-up are warranted.
- 1 May 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (5) , 475
Open AccessPacemaker implantation after concomitant maze procedure and mitral valve repair in atrial functional mitral regurgitation
Background: Atrial functional mitral regurgitation (AFMR) is caused by atrial enlargement and mitral annular dilation due to atrial fibrillation (AF). Although the outcomes of mitral valve surgery in AFMR have been reported, concomitant Maze procedure outcomes in AFMR remain poorly understood. This study aimed to evaluate the clinical and rhythm outcomes of concomitant mitral valve plasty and the Maze procedure in patients with AFMR. Methods: We retrospectively analyzed 122 patients who underwent the mitral valve plasty (repair) concomitant with Maze procedure between August 2010 and June 2025. The cohort was divided into an AFMR group (n=50) and a non-AFMR group (n=72). The cumulative incidence of permanent pacemaker (PPM) implantation was analyzed using the Fine-Gray subdistribution hazard model with death as a competing risk. Postoperative rhythm dynamics were evaluated using a continuous-time multi-state Markov model. Results: The overall cumulative incidence of PPM implantation was significantly higher in the AFMR group than in the non-AFMR group (P30 days) PPM implantation (PConclusions: AFMR was not associated with a statistically significant difference in overall survival and the incidence of major adverse cardiovascular events following the Maze procedure compared to the non-AFMR group. However, AFMR was associated with a higher risk of transition to junctional rhythm following the Maze procedure, which was associated with an increased rate of PPM implantation. Notably, the risk of pacemaker implantation was predominantly late-onset, which may be due to a progressive decline in sinus node function. Therefore, close long-term rhythm monitoring and follow-up are warranted.
- Open Access
- 20 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 3127
Impact of Improved End-Stage Renal Disease Patient Survival on Prosthetic Valve Selection in Aortic Valve Replacement: A Nationwide Cohort Analysis
Background: Earlier studies in patients with end-stage renal dysfunction (ESRD) reported no significant difference in long-term outcomes between mechanical and tissue valves after valve surgery, largely due to the limited life expectancy of this population. As survival in patients with ESRD has improved in recent years, this study evaluated whether increased life expectancy affects long-term outcomes according to valve type in patients with ESRD undergoing aortic valve replacement (AVR) using a nationwide cohort. Methods: We analyzed data from the Korean National Health Insurance Service database from January 2005 to December 2021. Among 474 patients with ESRD who underwent AVR, 279 received tissue valves and 195 received mechanical valves. Propensity score matching was performed to balance baseline characteristics, yielding 99 matched patient pairs. Results: In the matched cohort, early mortality (within 30 days) was significantly higher in the tissue valve group (16.2% vs. 4.0%; p = 0.008). However, long-term survival rates at 1, 5, and 10 years did not differ significantly between the groups (all p > 0.05). Stratification by operative era (2005–2013 vs. 2014–2021) similarly showed no significant impact of valve type on survival despite temporal advances in care. Conclusions: Long-term survival and complication rates after AVR in patients with ESRD were comparable between mechanical and tissue valves across operative eras. Valve selection should be guided by shared decision-making, incorporating individual life expectancy and comorbidity profiles rather than assuming mechanical valves as the default option.
- 20 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 3127
Open AccessImpact of Improved End-Stage Renal Disease Patient Survival on Prosthetic Valve Selection in Aortic Valve Replacement: A Nationwide Cohort Analysis
Background: Earlier studies in patients with end-stage renal dysfunction (ESRD) reported no significant difference in long-term outcomes between mechanical and tissue valves after valve surgery, largely due to the limited life expectancy of this population. As survival in patients with ESRD has improved in recent years, this study evaluated whether increased life expectancy affects long-term outcomes according to valve type in patients with ESRD undergoing aortic valve replacement (AVR) using a nationwide cohort. Methods: We analyzed data from the Korean National Health Insurance Service database from January 2005 to December 2021. Among 474 patients with ESRD who underwent AVR, 279 received tissue valves and 195 received mechanical valves. Propensity score matching was performed to balance baseline characteristics, yielding 99 matched patient pairs. Results: In the matched cohort, early mortality (within 30 days) was significantly higher in the tissue valve group (16.2% vs. 4.0%; p = 0.008). However, long-term survival rates at 1, 5, and 10 years did not differ significantly between the groups (all p > 0.05). Stratification by operative era (2005–2013 vs. 2014–2021) similarly showed no significant impact of valve type on survival despite temporal advances in care. Conclusions: Long-term survival and complication rates after AVR in patients with ESRD were comparable between mechanical and tissue valves across operative eras. Valve selection should be guided by shared decision-making, incorporating individual life expectancy and comorbidity profiles rather than assuming mechanical valves as the default option.
- Open Access
- 1 February 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (2) , 95
Initial single-center experience with robot-assisted single-port major pulmonary resection: a retrospective study
Background: The da Vinci Single-Port (SP) system is a robotic platform designed to facilitate uniportal surgery. This study aimed to evaluate the feasibility and safety of the da Vinci SP system for major pulmonary resections. Methods: We retrospectively reviewed patients with non-small cell lung cancer who underwent lobectomy or segmentectomy using the da Vinci SP system between August 2023 and June 2025. All procedures were performed through a uniportal subcostal incision. The primary endpoint was procedural feasibility, defined as completion of the planned operation without conversion to an alternative surgical approach or the addition of any supplemental ports. Secondary endpoints included safety and perioperative outcomes. Results: Nine patients were included: 8 (88.9%) had clinical stage I disease, and 1 (11.1%) with clinical stage IIB received neoadjuvant chemoimmunotherapy. The median age was 55.0 (range, 40.0–70.0) years, and 6 patients (66.7%) were women. Lobectomy was performed in 7 patients (77.8%), and segmentectomy in 2 (22.2%). The median operative and console times were 198.0 (range, 141.0–248.0) min and 151.0 (range, 105.0–190.0) min, respectively. All procedures were completed without conversion, and complete resection was achieved in all cases. The median pathologic tumor size was 20.0 (range, 0.0–40.0) mm. A median of 8.0 lymph node (LN) stations and 22.0 LNs were harvested. No Clavien-Dindo grade ≥ III complications occurred. One patient (11.1%) developed chylothorax, which was managed conservatively. The median durations of chest tube drainage and hospital stay were 3 and 4 days, respectively. Conclusions: Robot-assisted SP major pulmonary resections via a uniportal subcostal approach appear feasible and safe, demonstrating acceptable short-term postoperative outcomes.
- 1 February 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (2) , 95
Open AccessInitial single-center experience with robot-assisted single-port major pulmonary resection: a retrospective study
Background: The da Vinci Single-Port (SP) system is a robotic platform designed to facilitate uniportal surgery. This study aimed to evaluate the feasibility and safety of the da Vinci SP system for major pulmonary resections. Methods: We retrospectively reviewed patients with non-small cell lung cancer who underwent lobectomy or segmentectomy using the da Vinci SP system between August 2023 and June 2025. All procedures were performed through a uniportal subcostal incision. The primary endpoint was procedural feasibility, defined as completion of the planned operation without conversion to an alternative surgical approach or the addition of any supplemental ports. Secondary endpoints included safety and perioperative outcomes. Results: Nine patients were included: 8 (88.9%) had clinical stage I disease, and 1 (11.1%) with clinical stage IIB received neoadjuvant chemoimmunotherapy. The median age was 55.0 (range, 40.0–70.0) years, and 6 patients (66.7%) were women. Lobectomy was performed in 7 patients (77.8%), and segmentectomy in 2 (22.2%). The median operative and console times were 198.0 (range, 141.0–248.0) min and 151.0 (range, 105.0–190.0) min, respectively. All procedures were completed without conversion, and complete resection was achieved in all cases. The median pathologic tumor size was 20.0 (range, 0.0–40.0) mm. A median of 8.0 lymph node (LN) stations and 22.0 LNs were harvested. No Clavien-Dindo grade ≥ III complications occurred. One patient (11.1%) developed chylothorax, which was managed conservatively. The median durations of chest tube drainage and hospital stay were 3 and 4 days, respectively. Conclusions: Robot-assisted SP major pulmonary resections via a uniportal subcostal approach appear feasible and safe, demonstrating acceptable short-term postoperative outcomes.
- Open Access
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67
The Impact of Continuous Renal Replacement Therapy on the Development of Thrombocytopenia During Extracorporeal Membrane Oxygenation
Woo JU, et al. Yonsei Med J. 2026 ;67:e68. https://doi.org/10.3349/ymj.2025.0554
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67
Open AccessThe Impact of Continuous Renal Replacement Therapy on the Development of Thrombocytopenia During Extracorporeal Membrane Oxygenation
Woo JU, et al. Yonsei Med J. 2026 ;67:e68. https://doi.org/10.3349/ymj.2025.0554
- Open Access
- 21 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8291
Atrial Functional Mitral Regurgitation Is a Risk Factor for Permanent Pacemaker Implantation
Background and Objectives: This study aimed to investigate risk factors for permanent pacemaker (PPM) implantation following the Maze procedure in patients with atrial functional mitral regurgitation (AFMR). Methods: A retrospective cohort of 423 patients who underwent the Maze procedure for persistent or paroxysmal atrial fibrillation from 2010 to 2025 was analyzed. Patients were categorized on the basis of the need for PPM postoperatively. Risk factors and rhythm outcomes were compared using multivariable Cox and logistic regression with backward stepwise selection according to the Akaike Information Criterion. Results: Forty-five patients (10.6%) required PPM implantation following the Maze procedure. The PPM group demonstrated a significantly higher AFMR prevalence than the non-PPM group (28.9% vs. 10.4%, p = 0.001). Preoperative fine P waves and older age were additional significant predictors. The PPM group exhibited lower postoperative sinus rhythm rates and higher junctional rhythm rates. AFMR (hazard ratio [HR], 2.10; p = 0.030), fine P wave (HR, 2.03; p = 0.049), and age (HR, 1.04; p = 0.018) independently predicted PPM implantation. AFMR particularly elevated the late PPM implantation risk. Conclusions: AFMR is an independent risk factor for late nodal dysfunction requiring PPM following Maze procedures. To detect delayed pacemaker requirements postoperatively, extended monitoring is recommended for patients with AFMR.
- 21 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8291
Open AccessAtrial Functional Mitral Regurgitation Is a Risk Factor for Permanent Pacemaker Implantation
Background and Objectives: This study aimed to investigate risk factors for permanent pacemaker (PPM) implantation following the Maze procedure in patients with atrial functional mitral regurgitation (AFMR). Methods: A retrospective cohort of 423 patients who underwent the Maze procedure for persistent or paroxysmal atrial fibrillation from 2010 to 2025 was analyzed. Patients were categorized on the basis of the need for PPM postoperatively. Risk factors and rhythm outcomes were compared using multivariable Cox and logistic regression with backward stepwise selection according to the Akaike Information Criterion. Results: Forty-five patients (10.6%) required PPM implantation following the Maze procedure. The PPM group demonstrated a significantly higher AFMR prevalence than the non-PPM group (28.9% vs. 10.4%, p = 0.001). Preoperative fine P waves and older age were additional significant predictors. The PPM group exhibited lower postoperative sinus rhythm rates and higher junctional rhythm rates. AFMR (hazard ratio [HR], 2.10; p = 0.030), fine P wave (HR, 2.03; p = 0.049), and age (HR, 1.04; p = 0.018) independently predicted PPM implantation. AFMR particularly elevated the late PPM implantation risk. Conclusions: AFMR is an independent risk factor for late nodal dysfunction requiring PPM following Maze procedures. To detect delayed pacemaker requirements postoperatively, extended monitoring is recommended for patients with AFMR.
- 28 October 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (11)
Comparison of Short-Term Surgical Outcomes for Thymectomy With Various Minimally Invasive Approaches: A Single-Centre Experience
Objectives: Minimally invasive thymectomy, encompassing video-assisted thoracoscopic surgery and robotic-assisted thoracic surgery, is increasingly being adopted as an alternative to sternotomy. However, comparative data on commonly used minimally invasive techniques remain limited. This study aimed to compare the short-term surgical outcomes of 3 approaches: lateral video-assisted thoracoscopic surgery, lateral robotic-assisted thoracic surgery and subxiphoid robotic-assisted thoracic surgery. Methods: We retrospectively reviewed 292 patients who underwent minimally invasive thymectomy for anterior mediastinal masses between October 2020 and April 2024. Patients were categorized into 3 groups according to the surgical approach. Perioperative outcomes, including operating time, postoperative pain, hospital stay, and complications, were compared. Results: Of the 292 patients, 155 underwent lateral video-assisted thoracoscopic surgery; 70 underwent lateral robotic-assisted thoracic surgery; and 67 underwent subxiphoid robotic-assisted thoracic surgery. Operative time was significantly longer in both robotic-assisted thoracic surgery groups compared to video-assisted thoracoscopic surgery (lateral robotic-assisted thoracic surgery: 118.7 min; subxiphoid robotic-assisted thoracic surgery: 116.7 min; video-assisted thoracoscopic surgery: 93.5 min; P < .001). No significant differences were observed among the 3 groups in terms of postoperative pain, chest tube duration, hospital stay, complication rate, or R0 resection. No in-hospital deaths occurred. Conclusions: All 3 minimally invasive approaches for thymectomy demonstrated comparable short-term outcomes, although robotic-assisted thoracic surgery procedures had longer operating times. These findings suggest that lateral video-assisted thoracoscopic surgery, lateral robotic-assisted thoracic surgery, and subxiphoid robotic-assisted thoracic surgery are all safe and effective options, enabling surgeons to select the most appropriate technique based on individual patient characteristics and their surgical expertise.
- 28 October 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (11)
Comparison of Short-Term Surgical Outcomes for Thymectomy With Various Minimally Invasive Approaches: A Single-Centre Experience
Objectives: Minimally invasive thymectomy, encompassing video-assisted thoracoscopic surgery and robotic-assisted thoracic surgery, is increasingly being adopted as an alternative to sternotomy. However, comparative data on commonly used minimally invasive techniques remain limited. This study aimed to compare the short-term surgical outcomes of 3 approaches: lateral video-assisted thoracoscopic surgery, lateral robotic-assisted thoracic surgery and subxiphoid robotic-assisted thoracic surgery. Methods: We retrospectively reviewed 292 patients who underwent minimally invasive thymectomy for anterior mediastinal masses between October 2020 and April 2024. Patients were categorized into 3 groups according to the surgical approach. Perioperative outcomes, including operating time, postoperative pain, hospital stay, and complications, were compared. Results: Of the 292 patients, 155 underwent lateral video-assisted thoracoscopic surgery; 70 underwent lateral robotic-assisted thoracic surgery; and 67 underwent subxiphoid robotic-assisted thoracic surgery. Operative time was significantly longer in both robotic-assisted thoracic surgery groups compared to video-assisted thoracoscopic surgery (lateral robotic-assisted thoracic surgery: 118.7 min; subxiphoid robotic-assisted thoracic surgery: 116.7 min; video-assisted thoracoscopic surgery: 93.5 min; P < .001). No significant differences were observed among the 3 groups in terms of postoperative pain, chest tube duration, hospital stay, complication rate, or R0 resection. No in-hospital deaths occurred. Conclusions: All 3 minimally invasive approaches for thymectomy demonstrated comparable short-term outcomes, although robotic-assisted thoracic surgery procedures had longer operating times. These findings suggest that lateral video-assisted thoracoscopic surgery, lateral robotic-assisted thoracic surgery, and subxiphoid robotic-assisted thoracic surgery are all safe and effective options, enabling surgeons to select the most appropriate technique based on individual patient characteristics and their surgical expertise.
- Open Access
- 30 November 2023
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 40 (Suppl) , S23-S28
Surgical results of only antegrade del Nido cardioplegia infusion in conventional coronary artery bypass grafting: a retrospective study
Background: Additional retrograde cardioplegia infusion in conventional coronary artery bypass grafting (CABG) was introduced to address the concern of inappropriate cardioplegia delivery through the stenotic coronary artery. However, this method is complex and requires repeated infusions. Therefore, we investigated the surgical outcomes of only antegrade cardioplegia infusion in conventional CABG.Methods: We included 224 patients who underwent isolated CABG between 2017 and 2019. The patients were divided into two groups according to the cardioplegia infusion method: antegrade cardioplegia infusion with del Nido solution (n=111, group I) and antegrade+retrograde cardioplegia infusion with blood cardioplegia solution (n=113, group II).Results: The sinus recovery time after release of the aorta cross-clamp was shorter in group I (3.8±7.1 minutes, n=98) than in group II (5.8±4.1 minutes, n=73) (p=0.033). The total cardioplegia infusion volume was lower in group I (1,998.6±668.6 mL) than in group II (7,321.0±2,865.3 mL) (p<0.001). Creatine kinase-MB levels were significantly lower in group I than in group II (p=0.039). Newly developed regional wall motion abnormalities on follow-up echocardiography were detected in two patients (1.8%) in group I and five patients (4.4%) in group II (p=0.233). There was no significant difference in ejection fraction improvement between the two groups (3.3%±9.3% in group I and 3.3%±8.7% in group II, p=0.990).Conclusion: The only antegrade cardioplegia infusion strategy in conventional CABG is safe and has no harmful effects.
- 30 November 2023
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 40 (Suppl) , S23-S28
Open AccessSurgical results of only antegrade del Nido cardioplegia infusion in conventional coronary artery bypass grafting: a retrospective study
Background: Additional retrograde cardioplegia infusion in conventional coronary artery bypass grafting (CABG) was introduced to address the concern of inappropriate cardioplegia delivery through the stenotic coronary artery. However, this method is complex and requires repeated infusions. Therefore, we investigated the surgical outcomes of only antegrade cardioplegia infusion in conventional CABG.Methods: We included 224 patients who underwent isolated CABG between 2017 and 2019. The patients were divided into two groups according to the cardioplegia infusion method: antegrade cardioplegia infusion with del Nido solution (n=111, group I) and antegrade+retrograde cardioplegia infusion with blood cardioplegia solution (n=113, group II).Results: The sinus recovery time after release of the aorta cross-clamp was shorter in group I (3.8±7.1 minutes, n=98) than in group II (5.8±4.1 minutes, n=73) (p=0.033). The total cardioplegia infusion volume was lower in group I (1,998.6±668.6 mL) than in group II (7,321.0±2,865.3 mL) (p<0.001). Creatine kinase-MB levels were significantly lower in group I than in group II (p=0.039). Newly developed regional wall motion abnormalities on follow-up echocardiography were detected in two patients (1.8%) in group I and five patients (4.4%) in group II (p=0.233). There was no significant difference in ejection fraction improvement between the two groups (3.3%±9.3% in group I and 3.3%±8.7% in group II, p=0.990).Conclusion: The only antegrade cardioplegia infusion strategy in conventional CABG is safe and has no harmful effects.
- Open Access
- 5 October 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (5) , 393-395
Anomalous Connection of Umbilical Vessels to the Left Ventricle: Case Report
Yo Han Bae, M.D., Woo Sung Jang, M.D., Ph.D., Hee Joung Choi, M.D., So Young Shin, M.D.. Korean J Thorac Cardiovasc Surg -0001;0:. https://doi.org/10.5090/kjtcs.20.114
- 5 October 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (5) , 393-395
Open AccessAnomalous Connection of Umbilical Vessels to the Left Ventricle: Case Report
Yo Han Bae, M.D., Woo Sung Jang, M.D., Ph.D., Hee Joung Choi, M.D., So Young Shin, M.D.. Korean J Thorac Cardiovasc Surg -0001;0:. https://doi.org/10.5090/kjtcs.20.114
- Open Access
- 5 February 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (1) , 45-52
Time Course of Ventricular Remodeling after Atrial Septal Defect Closure in Adult Patients
Yo Han Bae, M.D., Woo Sung Jang, M.D., Ph.D., Jin Young Kim, M.D., Yun Seok Kim, M.D., Ph.D.. J Chest Surg 2021;54:45-52. https://doi.org/10.5090/kjtcs.20.098
- 5 February 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (1) , 45-52
Open AccessTime Course of Ventricular Remodeling after Atrial Septal Defect Closure in Adult Patients
Yo Han Bae, M.D., Woo Sung Jang, M.D., Ph.D., Jin Young Kim, M.D., Yun Seok Kim, M.D., Ph.D.. J Chest Surg 2021;54:45-52. https://doi.org/10.5090/kjtcs.20.098